Annette Mattsson
General Counsel en CAMURUS AB .
Fortuna: 142 578 $ al 31/03/2024
Perfil
Annette Mattsson is currently working as Vice President-Regulatory Affairs at Camurus AB since 2019.
Prior to this, she worked as Director-European RA at AstraZeneca AB.
Ms. Mattsson completed her undergraduate degree from the University of Uppsala and the University of Lund.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CAMURUS AB
0.01% | 15/12/2023 | 3 004 ( 0.01% ) | 142 578 $ | 31/03/2024 |
Cargos activos de Annette Mattsson
| Empresas | Cargo | Inicio |
|---|---|---|
| CAMURUS AB | General Counsel | 01/01/2019 |
Antiguos cargos conocidos de Annette Mattsson.
| Empresas | Cargo | Fin |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Formación de Annette Mattsson.
| University of Uppsala | Undergraduate Degree |
| University of Lund | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CAMURUS AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Bolsa de valores
- Insiders
- Annette Mattsson
